Abstract
Classically, cardiogenic shock has been considered a sequela of ST-segment elevation myocardial infarction, most commonly caused by left ventricular dysfunction resulting from ongoing ischemia and cell necrosis. In keeping with this scenario, most of the current literature on cardiogenic shock confines itself to ST-segment elevation. It must be remembered, however, that Herrick’s classic description of cardiogenic shock in 1912 predated the discovery and application of electrocardiography, emphasizing the important fact that in the setting of acute myocardial infarction, shock may occur irrespective of the direction of the electrocardiographic abnormalities.
A man aged 55 in good health was seized with severe pain in the lower precordial region. When I saw him twelve hours from the attack, there was moderate cyanosis and mild dyspnea. The chest was full of fine and coarse moist rales; there was a running feeble pulse of 140. Urine was scanty.
Herrick, Dec. 7, 1912
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Furman MI, Dauerman HL, Goldberg RJ, Yarzbeski J, Lessard D, Gore JM. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and nonQ-wave myocardial infarction: a multi-hospital community-wide perspective. J Am Coll Cardiol 2001; 37: 1571–1580.
The GUSTO IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996; 335: 775–782.
Holmes DR Jr, Berger PB, Hochman JS, et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999; 100: 2067–2073.
Jacobs AK, French JK, Col J, et al. Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 2000; 36 (3 suppl A): 1091–1096.
Hasdai D, Harrington RA, Hochman JS, et al. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. J Am Coll Cardiol 2000; 36: 685–692.
Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. Circulation 1995; 91: 873–881.
Hasdai D, Calif RM, Thompson TD, et al. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 2000; 35: 136–143.
Berger PB, Holmes DR Jr, Stebbins A, Bates ER, Califf RM, Topol EJ. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO I) trial. Circulation 1997; 96: 122–127.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Holmes, D.R., Hasdai, D. (2002). Cardiogenic Shock Complicating Non—ST-Segment Elevation Acute Coronary Syndrome. In: Hasdai, D., Berger, P.B., Battler, A., Holmes, D.R. (eds) Cardiogenic Shock. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-154-1_3
Download citation
DOI: https://doi.org/10.1007/978-1-59259-154-1_3
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-312-1
Online ISBN: 978-1-59259-154-1
eBook Packages: Springer Book Archive